Advanced Medical Solutions Group (LON:AMS) Receives Buy Rating from Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a report released on Tuesday, Marketbeat reports. They currently have a GBX 300 ($3.66) price objective on the stock.

Advanced Medical Solutions Group Stock Down 0.5 %

Shares of AMS stock opened at GBX 217 ($2.65) on Tuesday. The firm’s fifty day moving average price is GBX 204 and its two-hundred day moving average price is GBX 220.12. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. Advanced Medical Solutions Group has a 1 year low of GBX 176.60 ($2.16) and a 1 year high of GBX 275.83 ($3.37). The firm has a market capitalization of £465.57 million, a P/E ratio of 4,340.00, a PEG ratio of 5.00 and a beta of 0.74.

Insider Activity at Advanced Medical Solutions Group

In related news, insider Eddie Johnson sold 34,235 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of GBX 218 ($2.66), for a total value of £74,632.30 ($91,115.00). 3.12% of the stock is owned by company insiders.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.